Datasheet Inhibitors / Agonists / Screening Libraries a DRUG SCREENING EXPERT

Datasheet Inhibitors / Agonists / Screening Libraries a DRUG SCREENING EXPERT

Datasheet Inhibitors / Agonists / Screening Libraries A DRUG SCREENING EXPERT Product Name : Vanoxerine dihydrochloride Catalog Number : T7153 CAS Number : 67469-78-7 Molecular Formula : C28H34Cl2F2N2O Molecular Weight : 523.49 Description: Vanoxerine dihydrochloride is a potent inhibitor that blocks dopamine uptake (IC50 : 1-51 nM) Storage: 2 years -80°C in solvent; 3 years -20°C powder; DMSO 9.4 mg/mL (17.96 mM) Solubility ( < 1 mg/ml refers to the product slightly soluble or insoluble ) Receptor (IC50) dopamine uptake 1-51 nM In vivo Activity In 9 SP dogs, 11 episodes each of sustained (>10 minutes) AF and AFL were induced. Electrophysiological studies were performed before and after infusion of vanoxerine, which effectively terminated AF and AFL in 19 of 22 episodes. Simultaneous multisite mapping during 3 AF and 3 AFL episodes demonstrated that termination of each arrhythmia occurred with termination of the driver (a reentrant circuit) following an increase in tachycardia CL. Except for conduction in an area of slow conduction in the driver's reentrant circuit, vanoxerine did not significantly affect intraatrial or atrioventricular conduction time, QRS duration, or QT/QTc intervals. Ventricular refractoriness prolonged minimally during ventricular pacing at 400 and 333 ms (176 +/- 16 ms to 182 +/- 16 ms; 173 +/- 11 ms to 178 +/- 18 ms, respectively). Vanoxerine minimally increased (mean 0.7 mA) atrial stimulus threshold for capture[1].Vanoxerine dihydrochloridealso blocks ligand binding to sigma receptors in rat brain (IC50 = 48 nM)[2]. Reference 1. Vanoxerine, a New Drug for Terminating Atrial Fibrillation and Flutter[J]. J Cardiovasc Electrophysiol, 2010, 21(3):311-319. 2. Contreras P C , Bremer M E , Rao T S . GBR-12909 and fluspirilene potently inhibited binding of [3H] (+)3-PPP to sigma receptors in rat brain[J]. Life Sciences, 1990, 47(22):PL133-7. 3. Rothman R B , Baumann M H , Prisinzano T E , et al. Dopamine transport inhibitors based on GBR12909 and benztropine as potential medications to treat cocaine addiction[J]. Biochemical Pharmacology, 2008, 75(1):2-16. FOR RESEARCH PURPOSES ONLY. NOT FOR DIAGNOSTIC OR THERAPEUTIC USE. Information for product storage and handling is indicated on the product datasheet. Targetmol products are stable for long term under the recommended storage conditions. Our products may be shipped under different conditions as many of them are stable in the short-term at higher or even room temperatures. We ensure that the product is shipped under conditions that will maintain the quality of the reagents. Upon receipt of the product, please follow the storage recommendations on the product data sheet. [email protected] | Tel: +1-781-999-4286 | www.targetmol.com.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    1 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us